Related Experiment Video

Updated: Jul 5, 2026

Sleeve Gastrectomy in Mice using Surgical Clips
05:16

Sleeve Gastrectomy in Mice using Surgical Clips

Published on: November 14, 2020

[Anti-aging medicine in patients subjected to bariatric surgery]

Ludovico Abenavoli, Fabio Massimo Abenavoli

    Recenti Progressi in Medicina
    |May 8, 2008
    PubMed

    Insights

    Anti-aging medicine focuses on preventing and treating age-related diseases. Future applications may particularly benefit patients undergoing bariatric surgery, enhancing their long-term health outcomes.

    Area of Science:

    • Gerontology and Regenerative Medicine: Focuses on the scientific study of aging and the development of interventions to slow or reverse age-related decline.

    Background:

    • Anti-aging medicine aims to diagnose, prevent, and treat pathologies associated with aging.
    • It leverages technological advancements for proactive health management.

    Discussion:

    • The integration of anti-aging strategies holds significant potential for improving patient outcomes.
    • Bariatric surgery patients represent a key demographic that could greatly benefit from these advancements.

    Key Insights:

    • Early diagnosis and prevention are central to managing age-related conditions.
    • Personalized therapeutic approaches are crucial in anti-aging medicine.

    Outlook:

    • Future advancements in anti-aging medicine promise broader accessibility and application.
    • Enhanced patient care, particularly post-bariatric surgery, is a foreseeable benefit.

    More Related Videos

    Techniques of Sleeve Gastrectomy and Modified Roux-en-Y Gastric Bypass in Mice10:05

    Techniques of Sleeve Gastrectomy and Modified Roux-en-Y Gastric Bypass in Mice

    Published on: March 20, 2017

    White and Brown Adipose Grafts: An Approach to Correct Reproductive, Metabolic, and Renal Deficits in Black and Tan Brachyury (BTBR) Obese Mice06:16

    White and Brown Adipose Grafts: An Approach to Correct Reproductive, Metabolic, and Renal Deficits in Black and Tan Brachyury (BTBR) Obese Mice

    Published on: September 9, 2025

    Related Concept Videos

    Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

    Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

    Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
    Drug Dosing: Obese Patients01:21

    Drug Dosing: Obese Patients

    In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
    Insulin: Dosing Regimen and Adverse Effects01:16

    Insulin: Dosing Regimen and Adverse Effects

    Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
    The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
    Gastritis-II: Pathophysiology01:17

    Gastritis-II: Pathophysiology

    Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
    In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
    In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
    Gastritis can stem from various causes, each...